3

FORM 3 SUBMISSION

Company: Monte Rosa Therapeutics, Inc.
Filed: June 23, 2021
Period of Report: June 23, 2021
Accession Number: 0000899243-21-025635

View Document ↗ View on SEC.gov ↗